
Christopher C. Caillouet
Examiner (ID: 8951, Phone: (571)270-3968 , Office: P/1745 )
| Most Active Art Unit | 1745 |
| Art Unit(s) | 1791, 1745 |
| Total Applications | 862 |
| Issued Applications | 546 |
| Pending Applications | 67 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8892472
[patent_doc_number] => 20130165656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-27
[patent_title] => 'CONTINUOUS PROCESS FOR THE ALKYLATION OF CYCLIC TERTIARY AMINES'
[patent_app_type] => utility
[patent_app_number] => 13/683448
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2778
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13683448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/683448 | Continuous process for the alkylation of cyclic tertiary amines | Nov 20, 2012 | Issued |
Array
(
[id] => 10175939
[patent_doc_number] => 09206128
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-08
[patent_title] => 'Modulators of methyl modifying enzymes, compositions and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/358558
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 85745
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358558
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358558 | Modulators of methyl modifying enzymes, compositions and uses thereof | Nov 18, 2012 | Issued |
Array
(
[id] => 8744922
[patent_doc_number] => 20130084639
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'Bicyclic Derivatives as Modulators of Ion Channels'
[patent_app_type] => utility
[patent_app_number] => 13/679028
[patent_app_country] => US
[patent_app_date] => 2012-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18179
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13679028
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/679028 | Bicyclic derivatives as modulators of ion channels | Nov 15, 2012 | Issued |
Array
(
[id] => 10906244
[patent_doc_number] => 20140309257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-16
[patent_title] => 'TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/357249
[patent_app_country] => US
[patent_app_date] => 2012-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11138
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14357249
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/357249 | TOPOISOMERASE INHIBITORS AND METHODS OF MAKING AND USE AS THERAPEUTIC AGENTS | Nov 12, 2012 | Abandoned |
Array
(
[id] => 9757609
[patent_doc_number] => 20140288310
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-25
[patent_title] => '7--6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID CRYSTAL'
[patent_app_type] => utility
[patent_app_number] => 14/352141
[patent_app_country] => US
[patent_app_date] => 2012-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10424
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352141
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/352141 | 7-{(3S,4S)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluorodethyl)-acid crystal | Nov 8, 2012 | Issued |
Array
(
[id] => 8708632
[patent_doc_number] => 20130065921
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-14
[patent_title] => 'PTEN INHIBITOR OR MAXI-K CHANNELS OPENER'
[patent_app_type] => utility
[patent_app_number] => 13/671448
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4419
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13671448
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/671448 | PTEN inhibitor or Maxi-K channels opener | Nov 6, 2012 | Issued |
Array
(
[id] => 10912838
[patent_doc_number] => 20140315857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-23
[patent_title] => 'N- (4 -QUINOLINYLMETHYL) SULFONAMIDE DERIVATIVES AND THEIR USE AS ANTHELMINTICS'
[patent_app_type] => utility
[patent_app_number] => 14/358196
[patent_app_country] => US
[patent_app_date] => 2012-11-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34481
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358196
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/358196 | N- (4 -QUINOLINYLMETHYL) SULFONAMIDE DERIVATIVES AND THEIR USE AS ANTHELMINTICS | Nov 6, 2012 | Abandoned |
Array
(
[id] => 9135852
[patent_doc_number] => 20130296567
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'BISAZOLE-BASED COMPOUND AND GROUP VIII TRANSITION METAL COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 13/668025
[patent_app_country] => US
[patent_app_date] => 2012-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6768
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668025
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/668025 | Bisazole-based compound and group VIII transition metal complex | Nov 1, 2012 | Issued |
Array
(
[id] => 10933240
[patent_doc_number] => 20140336262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-13
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS COMPRISING NAPTHAMIDES'
[patent_app_type] => utility
[patent_app_number] => 14/355926
[patent_app_country] => US
[patent_app_date] => 2012-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12675
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355926
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355926 | Pharmaceutical compositions comprising napthamides | Nov 1, 2012 | Issued |
Array
(
[id] => 9086564
[patent_doc_number] => 08557993
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-10-15
[patent_title] => 'Crystalline forms of pitavastatin calcium'
[patent_app_type] => utility
[patent_app_number] => 13/664498
[patent_app_country] => US
[patent_app_date] => 2012-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 4599
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13664498
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/664498 | Crystalline forms of pitavastatin calcium | Oct 30, 2012 | Issued |
Array
(
[id] => 8745563
[patent_doc_number] => 20130085281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-04-04
[patent_title] => 'Preparation of Pyridonecarboxylic Acid Antibacterials'
[patent_app_type] => utility
[patent_app_number] => 13/663601
[patent_app_country] => US
[patent_app_date] => 2012-10-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7678
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13663601
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/663601 | Preparation of pyridonecarboxylic acid antibacterials | Oct 29, 2012 | Issued |
Array
(
[id] => 10579416
[patent_doc_number] => 09301526
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Compounds with nematicidal activity'
[patent_app_type] => utility
[patent_app_number] => 14/355382
[patent_app_country] => US
[patent_app_date] => 2012-10-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 71946
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14355382
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/355382 | Compounds with nematicidal activity | Oct 28, 2012 | Issued |
Array
(
[id] => 9772573
[patent_doc_number] => 20140296236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'QUINOLINES AS FGFR KINASE MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 14/354773
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67409
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354773
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/354773 | Quinolines as FGFR kinase modulators | Oct 25, 2012 | Issued |
Array
(
[id] => 10019529
[patent_doc_number] => 09062000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Bis-quinaldine compound and a process for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 14/353639
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3589
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353639
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353639 | Bis-quinaldine compound and a process for preparing the same | Oct 21, 2012 | Issued |
Array
(
[id] => 10019734
[patent_doc_number] => 09062206
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-06-23
[patent_title] => 'Bis-quinophthalone pigment and a process for preparing the same'
[patent_app_type] => utility
[patent_app_number] => 14/353442
[patent_app_country] => US
[patent_app_date] => 2012-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2901
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14353442
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/353442 | Bis-quinophthalone pigment and a process for preparing the same | Oct 21, 2012 | Issued |
Array
(
[id] => 8660157
[patent_doc_number] => 20130040986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'Modulators of Cystic Fibrosis Transmembrane Conductance Regulator'
[patent_app_type] => utility
[patent_app_number] => 13/652056
[patent_app_country] => US
[patent_app_date] => 2012-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18335
[patent_no_of_claims] => 73
[patent_no_of_ind_claims] => 28
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652056
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/652056 | Modulators of cystic fibrosis transmembrane conductance regulator | Oct 14, 2012 | Issued |
Array
(
[id] => 9216363
[patent_doc_number] => 08629162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-01-14
[patent_title] => 'Modulators of ATP-binding cassette transporters'
[patent_app_type] => utility
[patent_app_number] => 13/647034
[patent_app_country] => US
[patent_app_date] => 2012-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 89500
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13647034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/647034 | Modulators of ATP-binding cassette transporters | Oct 7, 2012 | Issued |
Array
(
[id] => 10070575
[patent_doc_number] => 09108918
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-08-18
[patent_title] => 'Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate'
[patent_app_type] => utility
[patent_app_number] => 14/350108
[patent_app_country] => US
[patent_app_date] => 2012-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6343
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14350108
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/350108 | Process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(R)-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one via a novel intermediate | Oct 1, 2012 | Issued |
Array
(
[id] => 9937645
[patent_doc_number] => 08987456
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-03-24
[patent_title] => '3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/349563
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18827
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349563
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349563 | 3-pyridyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors | Sep 30, 2012 | Issued |
Array
(
[id] => 9958238
[patent_doc_number] => 09006444
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/349558
[patent_app_country] => US
[patent_app_date] => 2012-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12990
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14349558
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/349558 | Phenyl carboxamide-containing spleen tyrosine kinase (SYK) inhibitors | Sep 30, 2012 | Issued |